Helena Prokhorenko is an Associate with Highland Europe focused on identifying, evaluating and executing growth stage technology investments.
Helena currently works with Huel.
Prior to joining Highland, Helena spent two years in the Healthcare Investment Banking team at Bank of America Merrill Lynch, where she worked on a range of transactions involving M&A, debt and equity-linked financing, and IPOs, with a focus on major pharma, biotech, and consumer health. She was part of the core deal team advising Boehringer Ingelheim on its asset swap with Sanofi. She previously interned at NeuroVigil, a neurodiagnostics startup in California, where she was involved with business development and strategy projects.
Helena completed a four-year Biochemistry degree at the University of Oxford (MBiochem) and also holds a Masters in Management from London Business School (MSc). Born in the Ukraine and raised in Germany, Helena’s interests include boxing, cycling, and good food. She is also a keen follower of the Harlequins Rugby Club and enjoys playing the violin.